Skip to main content
Journal cover image

Cost Effectiveness of Pegfilgrastim for Reducing Incidence of Febrile Neutropenia Events after Cytotoxic Chemotherapy for Solid Tumors in Turkey

Publication ,  Conference
Saka, G; Villa, G; Worth, G; Barron, R; Malhan, S; Lyman, GH
Published in: Value in Health
May 2016

Duke Scholars

Published In

Value in Health

DOI

ISSN

1098-3015

Publication Date

May 2016

Volume

19

Issue

3

Start / End Page

A151 / A151

Publisher

Elsevier BV

Related Subject Headings

  • Health Policy & Services
  • 4407 Policy and administration
  • 4203 Health services and systems
  • 3801 Applied economics
  • 1402 Applied Economics
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Saka, G., Villa, G., Worth, G., Barron, R., Malhan, S., & Lyman, G. H. (2016). Cost Effectiveness of Pegfilgrastim for Reducing Incidence of Febrile Neutropenia Events after Cytotoxic Chemotherapy for Solid Tumors in Turkey. In Value in Health (Vol. 19, pp. A151–A151). Elsevier BV. https://doi.org/10.1016/j.jval.2016.03.1597
Saka, G., G. Villa, G. Worth, R. Barron, S. Malhan, and G. H. Lyman. “Cost Effectiveness of Pegfilgrastim for Reducing Incidence of Febrile Neutropenia Events after Cytotoxic Chemotherapy for Solid Tumors in Turkey.” In Value in Health, 19:A151–A151. Elsevier BV, 2016. https://doi.org/10.1016/j.jval.2016.03.1597.
Saka G, Villa G, Worth G, Barron R, Malhan S, Lyman GH. Cost Effectiveness of Pegfilgrastim for Reducing Incidence of Febrile Neutropenia Events after Cytotoxic Chemotherapy for Solid Tumors in Turkey. In: Value in Health. Elsevier BV; 2016. p. A151–A151.
Saka, G., et al. “Cost Effectiveness of Pegfilgrastim for Reducing Incidence of Febrile Neutropenia Events after Cytotoxic Chemotherapy for Solid Tumors in Turkey.” Value in Health, vol. 19, no. 3, Elsevier BV, 2016, pp. A151–A151. Crossref, doi:10.1016/j.jval.2016.03.1597.
Saka G, Villa G, Worth G, Barron R, Malhan S, Lyman GH. Cost Effectiveness of Pegfilgrastim for Reducing Incidence of Febrile Neutropenia Events after Cytotoxic Chemotherapy for Solid Tumors in Turkey. Value in Health. Elsevier BV; 2016. p. A151–A151.
Journal cover image

Published In

Value in Health

DOI

ISSN

1098-3015

Publication Date

May 2016

Volume

19

Issue

3

Start / End Page

A151 / A151

Publisher

Elsevier BV

Related Subject Headings

  • Health Policy & Services
  • 4407 Policy and administration
  • 4203 Health services and systems
  • 3801 Applied economics
  • 1402 Applied Economics
  • 1117 Public Health and Health Services